Brighthouse Financial Inc.

BHF-Q

NASDAQ:BHF

39.37
0.54 (1.35%)
Brighthouse Financial, Inc. is a major provider of annuities and life insurance in the U.S., with more than $220 billion in total assets and approximately 2.7 million insurance policies and annuity contracts in-force.
More at Wikipedia

Analysis and Opinions about BHF-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
August 14, 2019

(A Top Pick Aug 14/18, Down 17%) This was spun out last year from MetLife. It is the personal life side of the business. He sold it early in the year. As interest rates were going higher it made sense to own, but as rates moved lower he exited.

(A Top Pick Aug 14/18, Down 17%) This was spun out last year from MetLife. It is the personal life side of the business. He sold it early in the year. As interest rates were going higher it made sense to own, but as rates moved lower he exited.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$34.220
Owned
No
PAST TOP PICK
PAST TOP PICK
August 14, 2018

(A Top Pick August 18, 2017. Down 30%). This is a spinoff from MetLife. It is the personal insurance part of MetLife. The whole insurance group is down this year in double digits.

(A Top Pick August 18, 2017. Down 30%). This is a spinoff from MetLife. It is the personal insurance part of MetLife. The whole insurance group is down this year in double digits.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$41.090
Owned
Yes
TOP PICK
TOP PICK
August 14, 2018

This is the personal insurance business that was spun out of MetLife. Usually when companies are spun out, they go down for a while. However, there have been additional issues for this company. Interest rates have not gone up as expected. And the industry has been tarred with the brush of long-term care insurance costs and Veterans’ Affairs stuff. Brighthouse is not in the long-term care business but its price has been affected by the general concern and by the guarantees associated with Veterans’ issues. Brighthouse now trades at a significant discount to book value, about 0.4x, down from an earlier level of 0.7x. He considers this discount extreme. Brighthouse doesn’t pay a dividend or buy back shares, and won’t do so until 2020, so it is for patient investors. (Analysts’ price target is $49.69)

This is the personal insurance business that was spun out of MetLife. Usually when companies are spun out, they go down for a while. However, there have been additional issues for this company. Interest rates have not gone up as expected. And the industry has been tarred with the brush of long-term care insurance costs and Veterans’ Affairs stuff. Brighthouse is not in the long-term care business but its price has been affected by the general concern and by the guarantees associated with Veterans’ issues. Brighthouse now trades at a significant discount to book value, about 0.4x, down from an earlier level of 0.7x. He considers this discount extreme. Brighthouse doesn’t pay a dividend or buy back shares, and won’t do so until 2020, so it is for patient investors. (Analysts’ price target is $49.69)

Norman Levine
Managing Director, Portfolio Management Corp
Price
$41.090
Owned
Yes
TOP PICK
TOP PICK
August 18, 2017

It is a brand new company. It is the retail division of Met Life, who will continue with institutional life insurance. BHF-Q is doing variable rate annuities and personal insurance. The stock went down because some sold off the stock they received from the split up because they did not want to be bothered with it. They don’t yet pay a dividend and he does not see one until at least 2020. They will benefit from rising interest rates. (Analysts' target: $69.50).

It is a brand new company. It is the retail division of Met Life, who will continue with institutional life insurance. BHF-Q is doing variable rate annuities and personal insurance. The stock went down because some sold off the stock they received from the split up because they did not want to be bothered with it. They don’t yet pay a dividend and he does not see one until at least 2020. They will benefit from rising interest rates. (Analysts' target: $69.50).

Norman Levine
Managing Director, Portfolio Management Corp
Price
$57.450
Owned
Yes
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »